“Regenerative medicine” covers treatments that differ sharply in evidence, regulation, and risk. A platelet-rich plasma injection made from a patient’s blood is not the same product as cultured stem cells, umbilical tissue, amniotic fluid, or an exosome preparation sold by a private clinic. Grouping them together makes weak claims sound stronger than they are.
Some regenerative therapies are established medicine. Blood-forming stem cell transplantation has treated leukemia and other disorders for decades. Other approaches are promising but still experimental. A few orthopedic uses of platelet-rich plasma fall between those ends: evidence supports benefit for selected conditions, while marketing reaches much further.
What PRP Actually Contains
Platelet-rich plasma, or PRP, begins with a blood draw. A centrifuge separates and concentrates platelets in plasma, and the preparation is injected into an injured tendon or joint. Platelets release signaling molecules involved in clotting and tissue response.
There is no single PRP product. Concentration, white-cell content, activation method, injection volume, and number of treatments vary. Two clinics may both advertise PRP while delivering biologically different preparations. That variation makes research difficult to compare.
Where PRP Evidence Is Most Encouraging
Chronic Tendon Problems
PRP appears useful for some chronic tendinopathies, especially lateral epicondylitis, commonly called tennis elbow. Results are less consistent for acute muscle injuries, ligament sprains, and several surgical applications.
Knee Osteoarthritis
Some trials report pain and function improvement in mild to moderate knee osteoarthritis. The American Academy of Orthopaedic Surgeons describes evidence as promising for selected tendon injuries and lower-grade knee arthritis while noting that many other uses lack adequate support.
Symptom improvement does not mean cartilage was regrown. An AAOS technology review found limited evidence about structural change. Patients should ask whether the goal is pain relief, improved function, delayed surgery, or tissue restoration. Those are different claims.
What “Stem Cell Injection” May Mean
Clinics may use cells or tissue taken from bone marrow, fat, birth tissue, or other sources. Processing can range from same-day concentration to extensive manipulation. The source does not guarantee that a preparation contains a meaningful number of stem cells, that the cells remain active, or that they will become the tissue a patient needs.
Testimonials often describe pain improvement as proof of regeneration. Pain can change because of natural fluctuation, rehabilitation, placebo effects, accompanying injections, or reduced activity. Demonstrating new cartilage or nerve tissue requires stronger evidence.
The FDA Boundary Matters
The Food and Drug Administration warns that products marketed from fat-derived cells, umbilical tissue, amniotic fluid, Wharton’s jelly, and exosomes are often offered without approval. The agency states that the currently approved stem cell products in the United States are blood-forming cells derived from umbilical cord blood for disorders of the blood-producing system.
A clinic’s FDA registration is not product approval. A study appearing on ClinicalTrials.gov is not proof that the treatment has been reviewed or shown to work. For an investigational cellular product, patients can ask for the FDA-issued investigational new drug number and verify the trial independently.
Evidence Tier One: Established Uses
Hematopoietic stem cell transplantation is established for selected cancers and blood or immune disorders. Tissue grafts and certain cell-based products also have defined surgical uses. These treatments occur within specialized care, with standardized indications and monitoring.
Calling every injection “the same science” borrows credibility from these established therapies. The cell source, processing, intended function, clinical evidence, and regulatory status all matter.
Evidence Tier Two: Conditional or Emerging Uses
PRP for certain tendinopathies and knee osteoarthritis sits here. Benefits may be modest, protocols vary, insurance often does not cover treatment, and response is not guaranteed. Rehabilitation remains important.
Some cell or tissue therapies are being evaluated in legitimate clinical trials for orthopedic, neurologic, cardiac, and autoimmune conditions. Participation should include informed consent, oversight, eligibility criteria, adverse-event monitoring, and a clear explanation of costs.
Evidence Tier Three: Claims That Outrun Research
Be skeptical when one product is said to treat arthritis, dementia, autism, erectile dysfunction, lung disease, chronic fatigue, and aging. A biologically plausible story is not a clinical outcome.
Red flags include guarantees, claims of zero risk, pressure to pay immediately, vague descriptions of what is injected, packages costing many thousands of dollars, and testimonials used in place of controlled trials. Traveling abroad does not remove biological risk and may make follow-up harder.
Risks Are Not Merely Financial
PRP commonly causes temporary pain and carries the ordinary risks of an injection, including infection or injury. Cellular and tissue products may introduce contamination, immune reactions, abnormal tissue growth, clots, or cells in an unintended site.
The FDA has received reports involving infections, blindness, tumors, and neurologic events from unapproved regenerative products. Delaying proven treatment can also cause harm even when the injection itself produces no immediate complication.
Questions to Ask Before Paying
- What exactly is the product, and where does it come from?
- How is it processed and tested for contamination?
- Is this use FDA approved, or is it part of an FDA-overseen trial?
- Which controlled studies match my diagnosis and disease severity?
- Is the expected result pain relief, better function, or demonstrated tissue repair?
- What happens if symptoms worsen?
- Who manages complications after hours?
- What costs are not included in the advertised price?
Ask a clinician who does not sell the procedure to review the diagnosis and alternatives. For an orthopedic problem, clarify whether physical therapy, medication, activity modification, a standard injection, or surgery has stronger evidence.
Promise and Proof Can Coexist
Regenerative medicine is a serious field with valuable established treatments and important research underway. That scientific promise is precisely why standards matter. A treatment should be judged by its specific product, condition, protocol, comparison group, outcomes, and harms.
PRP may be reasonable for a narrow set of musculoskeletal problems after a careful discussion. Unapproved stem cell or exosome injections marketed as cures deserve far more caution. The label on the clinic door cannot substitute for evidence.